Cargando…
Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach
The aim of our study was to investigate cerebrospinal fluid (CSF) tryptic peptide profiles as potential diagnostic biomarkers for the discrimination of parkinsonian disorders. CSF samples were collected from individuals with parkinsonism, who had an uncertain diagnosis at the time of inclusion and w...
Autores principales: | Marques, Tainá M., van Rumund, Anouke, Kersten, Iris, Bruinsma, Ilona B., Wessels, Hans J.C.T., Gloerich, Jolein, Kaffa, Charlotte, Esselink, Rianne A. J., Bloem, Bastiaan R., Kuiperij, H. Bea, Verbeek, Marcel M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633286/ https://www.ncbi.nlm.nih.gov/pubmed/34848724 http://dx.doi.org/10.1038/s41531-021-00249-9 |
Ejemplares similares
-
Cerebrospinal Fluid Galectin-1 Levels Discriminate Patients with Parkinsonism from Controls
por: Marques, Tainá M., et al.
Publicado: (2018) -
MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System Atrophy
por: Marques, Tainá M., et al.
Publicado: (2016) -
Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson’s disease
por: Santaella, Anna, et al.
Publicado: (2020) -
Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
por: Santaella, Anna, et al.
Publicado: (2020) -
Proteomic profiling of striatal tissue of a rat model of Parkinson's disease after implantation of collagen‐encapsulated human umbilical cord mesenchymal stem cells
por: Santaella, Anna, et al.
Publicado: (2020)